EI24 antibody (C-Term)
Quick Overview for EI24 antibody (C-Term) (ABIN1450056)
Target
See all EI24 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, Mouse, Rat.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- 19 amino acid synthetic peptide near the carboxy terminus of Human EI24
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- EI24 (Etoposide Induced 2.4 (EI24))
-
Alternative Name
- EI24
-
Background
- The etoposide-induced 24 (EI24) protein is an immediate-early induction target of p53-mediated apoptosis and functions as a tumor suppressor. EI24 contains six transmembrane domains and is localized to the endoplasmic reticulum (ER). It binds to Bcl-2 and may contribute to apoptosis by modulating the activity and function of Bcl-2. EI24 is highly mutated in aggressive breast cancers and its loss in breast cancer tissue correlates with tumor invasiveness. Similar findings in invasive cervical carcinoma suggest that EI24 may be a promising therapeutic target in the treatment of invasive cancer.Synonyms: Etoposide-induced protein 2.4 homolog, PIG8, p53-induced gene 8 protein
-
Gene ID
- 9538
-
NCBI Accession
- NP_004870
Target
-